T1	Participants 112 219	percutaneous coronary intervention in chronic total occlusion--CAtholic Total Occlusion Study (CATOS) trial
T2	Participants 491 502	multicenter
T3	Participants 560 734	zotarolimus-eluting stent (ZES; Endeavor Sprint®, n=80) to a sirolimus-eluting stent (SES; Cypher®, n=80) in patients with CTO lesion with a reference vessel diameter ≥ 2.5mm
T4	Participants 1642 1683	patients undergoing PCI for CTO with DESs
